DOSSIER · 13F-HR · Q2 2026

ADAR1 Capital Management, LLC

$2.2B in tracked AUM across 277 positions as of Q2 2026.

AC
CIK 0001940272 · last filed Jun 30, 2026
Total AUM
$2.2B
as of Q2 2026
Holdings
277
positions
Whale Score
62
62
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

ADAR1 Capital Management, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
ABVX
ABIVAX SA
$246M1.8M11.3%
02
PTGX
PROTAGONIST THERAPEUTICS INC
$118M961K5.4%
03
SPY
STATE STR SPDR S&P 500 ETF T
$115M154K5.3%
04
G76279101
ROIVANT SCIENCES LTD
$112M3.2M5.1%
05
IMVT
IMMUNOVANT INC
$90M2.3M4.1%
06
ZLAB
ZAI LAB LTD
$64M3.4M2.9%
07
AGIO
AGIOS PHARMACEUTICALS INC
$48M1.3M2.2%
08
CRNX
CRINETICS PHARMACEUTICALS IN
$46M1.2M2.1%
09
BOXX
EA SERIES TRUST
$39M337K1.8%
10
CYTK
CYTOKINETICS INC
$39M458K1.8%

Filing history

2026Q2Jun 30
$2.2B 28.6%
277 positionsView →
2026Q1Mar 31
$1.7B 24.8%
311 positionsView →
2025Q4Dec 31
$1.4B 76.4%
270 positionsView →
2025Q3Sep 30
$772M 18.3%
163 positionsView →
2025Q2Jun 30
$652M 67.1%
210 positionsLocked
2025Q1Mar 31
$390M 22.0%
147 positionsLocked
2024Q4Dec 31
$500M 18.6%
214 positionsLocked
2024Q3Sep 30
$615M 16.1%
278 positionsLocked
2024Q2Jun 30
$530M 20.2%
266 positionsLocked
2024Q1Mar 31
$441M 57.5%
261 positionsLocked
2023Q4Dec 31
$280M
170 positionsLocked